- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05710913
Development of Machine Learning Models for the Prediction of BMI and Complications After Bariatric Surgery (CABS-Study)
January 25, 2023 updated by: Dr. Med Anas Taha
This Study aims to develop machine learning models with the ability to predict patients' BMI and complications after Bariatric Surgery (CABS-Score).
This Study also aims to develop machine learning models with the ability to predict diabetic (DM II)patients' remission rate after Bariatric Surgery.
The service mentioned above will be publicly available as a web-based application
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Anticipated)
10000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bassey Enodien, MD
- Email: Bassey.enodien@gzo.ch
Study Locations
-
-
-
Basel, Switzerland
- Recruiting
- University of Basel - Department of Biomedical Engineering
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing bariatric surgery
Description
Inclusion Criteria:
- Patients undergoing bariatric surgery
- Patients >18 years
Exclusion Criteria:
- Patients <18 years
- Patients who cannot be followed up on for more than 6 month after surgery
- Patients who are unable to provide informed approval to participate according to each centre's rules will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Complication after surgery
Time Frame: [Time Frame: From index surgery up to 3 months postoperatively]
|
[Time Frame: From index surgery up to 3 months postoperatively]
|
Body mass Index (KG/m2) after surgery
Time Frame: [Time Frame: From index surgery up to 1 year postoperatively]
|
[Time Frame: From index surgery up to 1 year postoperatively]
|
Diabetes mellitus type II remission rate postoperatively
Time Frame: [Time Frame: From index surgery up to 2 year postoperatively]
|
[Time Frame: From index surgery up to 2 year postoperatively]
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 5, 2023
Primary Completion (ANTICIPATED)
December 31, 2025
Study Completion (ANTICIPATED)
December 31, 2025
Study Registration Dates
First Submitted
January 15, 2023
First Submitted That Met QC Criteria
January 25, 2023
First Posted (ACTUAL)
February 2, 2023
Study Record Updates
Last Update Posted (ACTUAL)
February 2, 2023
Last Update Submitted That Met QC Criteria
January 25, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Glucose Metabolism Disorders
- Metabolic Diseases
- Nervous System Diseases
- Respiratory Tract Diseases
- Apnea
- Respiration Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Endocrine System Diseases
- Gastrointestinal Diseases
- Diabetes Mellitus
- Intestinal Diseases
- Pathological Conditions, Anatomical
- Sleep Apnea Syndromes
- Hernia, Diaphragmatic
- Intestinal Obstruction
- Sleep Apnea, Obstructive
- Diabetes Mellitus, Type 2
- Hernia
- Hernia, Hiatal
- Body Weight
- Postoperative Complications
- Hernia, Abdominal
- Internal Hernia
- Intussusception
Other Study ID Numbers
- CABS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Apnea, Obstructive
-
Mauro ManconiCompletedObstructive Sleep Apnea Syndrome | Sleep Apnea, Obstructive | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | OSAHSwitzerland
-
LivaNovaRecruitingApnea | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | Apnea+Hypopnea | Apnea, Obstructive Sleep | Hypopnea, SleepUnited States
-
University of California, Los AngelesRecruiting
-
Brigham and Women's HospitalCompletedObstructive Sleep Apnea (OSA)United States
-
State Budgetary Healthcare Institution, National...RecruitingObstructive Sleep Apnea | Obstructive Sleep Apnea-hypopnea | Obstructive Sleep Apnea-hypopnea SyndromeRussian Federation
-
The Hospital for Sick ChildrenCompleted
-
Cryosa, Inc.Active, not recruitingObstructive Sleep Apnea of AdultPanama, Paraguay
-
State Key Laboratory of Respiratory DiseaseCompletedObstructive Sleep Apnea of AdultChina
-
Somnics, Inc.UnknownObstructive Sleep Apnea of AdultTaiwan
-
ResMedCompletedObstructive Sleep Apnea (OSA)United States, Australia